Show simple item record

dc.contributor.editorZarros A
dc.contributor.editorJones EM
dc.contributor.editorTansey EM
dc.date.accessioned2017-06-08T13:28:21Z
dc.date.available2017-06-08T13:28:21Z
dc.date.issued2016
dc.date.submitted2017-06-08T12:29:12.496Z
dc.identifier.isbn9781910195208
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/23681
dc.description.abstractWith an introduction by Professor Jon Cohen, this Witness Seminar focuses on the recent history of TNF and its identification as a therapeutic target for rheumatoid arthritis and other diseases. The participants provide insights into how TNF has become a focal point for the study of inflammatory and malignant diseases, and discuss the obstacles and the opportunities that arose during the development of anti-TNF drugs.en_US
dc.language.isoenen_US
dc.relation.ispartofseriesWellcome Witnesses to Contemporary Medicine;Volume 60
dc.subjectWellcome Witnesses to Contemporary Medicineen_US
dc.subjectHistory of Modern Biomedicine Research Groupen_US
dc.titleThe Recent History of Tumour Necrosis Factor (TNF)en_US
dc.typeBooken_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record